Literature DB >> 7726630

Strategies to reduce mortality from cutaneous malignant melanoma.

R M MacKie1.   

Abstract

The incidence of cutaneous malignant melanoma continues to rise. Strategies to reduce mortality in this situation include improving therapy, encouraging earlier diagnosis, and promoting prevention. New developments such as epiluminescence, sentinel node biopsy, arterial limb perfusion and the use of vaccines are discussed in this context.

Entities:  

Mesh：

Year:  1994        PMID： 7726630     DOI： 10.1007/bf00370712

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


  14 in total

1.  Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future.

Authors:  B B Kroon
Journal:  Eur J Surg Oncol       Date:  1988-04       Impact factor: 4.424

2.  Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.

Authors:  U Veronesi; N Cascinelli; J Adamus; C Balch; D Bandiera; A Barchuk; R Bufalino; P Craig; J De Marsillac; J C Durand
Journal:  N Engl J Med       Date:  1988-05-05       Impact factor: 91.245

3.  An aid to the preoperative assessment of pigmented lesions of the skin.

Authors:  R M MacKie
Journal:  Br J Dermatol       Date:  1971-09       Impact factor: 9.302

4.  Cancer vaccines get a shot in the arm.

Authors:  J Cohen
Journal:  Science       Date:  1993-11-05       Impact factor: 47.728

Review 5.  Management of the regional lymph nodes in patients with cutaneous malignant melanoma.

Authors:  A J Cochran; D R Wen; D L Morton
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

6.  A preclinical model to assess the antigenicity of an HLA-A2 melanoma cell vaccine.

Authors:  Y Hayashi; D S Hoon; L J Foshag; M S Park; P I Terasaki; D L Morton
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

7.  In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma.

Authors:  A Steiner; H Pehamberger; K Wolff
Journal:  J Am Acad Dermatol       Date:  1987-10       Impact factor: 11.527

8.  Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan.

Authors:  J M Klaase; B B Kroon; A N van Geel; A M Eggermont; H R Franklin; A A Hart
Journal:  Surgery       Date:  1994-01       Impact factor: 3.982

Review 9.  Screening for melanoma/skin cancer: theoretic and practical considerations.

Authors:  H K Koh; R A Lew; M N Prout
Journal:  J Am Acad Dermatol       Date:  1989-02       Impact factor: 11.527

10.  Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

Authors:  D L Morton; L J Foshag; D S Hoon; J A Nizze; E Famatiga; L A Wanek; C Chang; D G Davtyan; R K Gupta; R Elashoff
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.